Peter A. McCullough
#12,752
Most Influential Person
American cardiologist and medical professor
Peter A. McCullough's AcademicInfluence.com Rankings
Philosophy
#3190
World Rank
#4791
Historical Rank
#992
USA Rank
Logic
#1368
World Rank
#2016
Historical Rank
#396
USA Rank
Why Is Peter A. McCullough Influential?
(Suggest an Edit or Addition)According to Wikipedia, Peter Andrew McCullough is an American cardiologist. He was vice chief of internal medicine at Baylor University Medical Center and a professor at Texas A&M University. During the COVID-19 pandemic, McCullough has promoted misinformation about COVID-19, its treatments, and mRNA vaccines.
Peter A. McCullough's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Papers
- Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. (2003) (4087)
- Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. (2002) (2742)
- Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. (2003) (1718)
- Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. (1997) (1669)
- K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease (2004) (1050)
- Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury (2013) (977)
- Combined angiotensin inhibition for the treatment of diabetic nephropathy. (2013) (953)
- B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure: Analysis From Breathing Not Properly (BNP) Multinational Study (2002) (913)
- Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative (2009) (874)
- Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. (2005) (827)
- Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). (2011) (786)
- Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. (2002) (575)
- B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. (2003) (525)
- Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. (2003) (501)
- Monitoring clinical changes in patients with heart failure: a comparison of methods. (2005) (491)
- Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. (2008) (465)
- Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. (2019) (454)
- Risk prediction of contrast-induced nephropathy. (2006) (450)
- Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. (2004) (438)
- Behavioral Predictors of Weight Regain after Bariatric Surgery (2010) (418)
- Epidemiology and prognostic implications of contrast-induced nephropathy. (2006) (416)
- BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. (2004) (376)
- Potential adverse cardiovascular effects from excessive endurance exercise. (2012) (369)
- Contrast-induced acute kidney injury. (2018) (352)
- Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology. (2004) (350)
- Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. (2012) (346)
- A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. (2006) (339)
- Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. (2003) (332)
- Ninety-Minute Exclusion of Acute Myocardial Infarction By Use of Quantitative Point-of-Care Testing of Myoglobin and Troponin I (2001) (321)
- Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. (2011) (307)
- A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy ☆: Results of the P.R.I.N.C.E. study (1999) (301)
- A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy ☆: Results of the P.R.I.N.C.E. study (1999) (301)
- Contrast-Induced Acute Kidney Injury. (2008) (301)
- How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. (2006) (276)
- Impact of obesity on cardiovascular disease. (2011) (272)
- Congestive heart failure and QRS duration: establishing prognosis study. (2002) (260)
- Pathophysiology of contrast-induced nephropathy. (2006) (259)
- The Pathophysiology of Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) (2008) (255)
- Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). (2010) (245)
- Strategies to reduce the risk of contrast-induced nephropathy. (2006) (240)
- Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. (2001) (240)
- Risks associated with renal dysfunction in patients in the coronary care unit. (2000) (236)
- Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. (2003) (235)
- Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). (2007) (232)
- Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. (2013) (226)
- Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers (2014) (219)
- Acute cardiac effects of marathon running. (2010) (216)
- B-type natriuretic peptides: a diagnostic breakthrough for clinicians. (2003) (209)
- Why is chronic kidney disease the "spoiler" for cardiovascular outcomes? (2003) (209)
- Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. (2002) (209)
- Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. (2010) (192)
- Epidemiology of contrast-induced nephropathy. (2003) (177)
- Accelerated atherosclerotic calcification and Monckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease. (2008) (177)
- Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. (2019) (177)
- A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial. (1998) (177)
- Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. (2008) (175)
- Contrast medium use. (2006) (173)
- Cardiorespiratory fitness and short-term complications after bariatric surgery. (2006) (170)
- Relationship between obesity and B-type natriuretic peptide levels. (2004) (170)
- Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. (2005) (169)
- Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. (2003) (167)
- Regional variation across the United States in the management of acute myocardial infarction. (1995) (167)
- Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program. (2005) (163)
- Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference (2018) (158)
- Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study. (2008) (155)
- Cardio-Pulmonary-Renal Interactions: A Multidisciplinary Approach. (2015) (153)
- Cardiorenal risk: an important clinical intersection. (2002) (151)
- CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. (2008) (150)
- Left ventricular thrombus and subsequent thromboembolism in patients with severe systolic dysfunction. (2000) (150)
- Trends in the incidence of acute kidney injury in patients hospitalized with acute myocardial infarction. (2012) (146)
- Obesity and age of first non-ST-segment elevation myocardial infarction. (2008) (145)
- Determinants of serum creatinine trajectory in acute contrast nephropathy. (2002) (144)
- The potential role and rationale for treatment of heart failure with sodium–glucose co‐transporter 2 inhibitors (2017) (144)
- Galectin-3: a novel blood test for the evaluation and management of patients with heart failure. (2011) (144)
- Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review. (2004) (142)
- Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States (2020) (142)
- Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspnea. (2004) (141)
- The role of oxidative stress in the metabolic syndrome. (2011) (141)
- Current Overview on Hypercoagulability in COVID-19 (2020) (140)
- Contrast-Induced Nephropathy (CIN) Consensus Working Panel: executive summary. (2006) (140)
- Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). (2011) (140)
- Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. (2009) (138)
- Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS‐9) in heart failure patients: results from a phase 3 randomized, double‐blind, placebo‐controlled trial (2015) (137)
- Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl (2014) (137)
- Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl. (2014) (136)
- Socioeconomic Status Is an Important Determinant of the Use of Invasive Procedures After Acute Myocardial Infarction in New York State (2000) (133)
- A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. (1999) (133)
- Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. (2003) (130)
- Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. (2007) (129)
- Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D). (2009) (128)
- Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study (2004) (124)
- Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). (2010) (124)
- B-Type Natriuretic Peptide and Renal Disease (2003) (120)
- Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. (1999) (120)
- Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy. (2020) (119)
- Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP). (2012) (118)
- Impact of Chronic Kidney Disease Upon Survival Among Implantable Cardioverter-Defibrillator Recipients (2004) (116)
- Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference. (2010) (116)
- Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES). (2009) (116)
- Contrast-induced nephropathy. (2005) (115)
- Low birth weight is associated with chronic kidney disease only in men. (2008) (114)
- Baseline renal function screening. (2006) (113)
- Changes in renal markers and acute kidney injury after marathon running (2011) (113)
- Class effects of SGLT2 inhibitors on cardiorenal outcomes (2019) (108)
- Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19 (2021) (106)
- Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery. (2007) (106)
- Cardiovascular implications of proteinuria: an indicator of chronic kidney disease (2009) (105)
- Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI). (2013) (105)
- Vitamin A Deficiency after Gastric Bypass Surgery: An Underreported Postoperative Complication (2010) (103)
- Cardiovascular Toxicity of Epoetin-Alfa in Patients with Chronic Kidney Disease (2013) (103)
- Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials. (2003) (103)
- Outcomes of contrast‐induced nephropathy: Experience in patients undergoing cardiovascular intervention (2006) (103)
- Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection (2020) (102)
- Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). (2013) (102)
- Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study. (2019) (100)
- Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). (2013) (99)
- Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. (2008) (99)
- Primary Care Detection of Chronic Kidney Disease in Adults with Type-2 Diabetes: The ADD-CKD Study (Awareness, Detection and Drug Therapy in Type 2 Diabetes and Chronic Kidney Disease) (2014) (98)
- Sorting out the evidence on natriuretic peptides. (2003) (97)
- Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease. (2016) (97)
- Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial. (2013) (96)
- An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trials. (2012) (93)
- Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing coronary angiography. (2010) (92)
- Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate. (2008) (92)
- Radiocontrast-Induced Acute Kidney Injury (2008) (91)
- Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications (2016) (89)
- B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea. (2005) (88)
- Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). (2013) (87)
- Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies. (2019) (87)
- Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the breathing not properly multinational study. (2005) (83)
- Cardiovascular disease in chronic kidney disease from a cardiologist's perspective (2004) (80)
- Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP). (2009) (80)
- Acute kidney injury with iodinated contrast (2008) (79)
- Annual progression of coronary calcification in trials of preventive therapies: a systematic review. (2009) (78)
- Arterial Stiffness in the Heart Disease of CKD. (2019) (78)
- Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD. (2021) (77)
- Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. (2010) (76)
- Awareness, knowledge, and perception of heart disease among adolescents (2006) (75)
- Curriculum in cardiology: integrated diagnosis and management of diastolic heart failure. (2007) (74)
- Renal dysfunction and acceleration of coronary disease (2004) (74)
- Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: a national online survey. (2008) (74)
- Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein. (2009) (74)
- Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease: A Scientific Statement From the American Heart Association (2020) (73)
- The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP). (2013) (73)
- Cardiovascular disease and chronic kidney disease: insights and an update. (2004) (72)
- The effect of weight loss after bariatric surgery on albuminuria. (2008) (72)
- Cardiovascular damage resulting from chronic excessive endurance exercise. (2012) (71)
- Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure. (2003) (71)
- In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke. (2010) (71)
- Educational programs improve the preparation for dialysis and survival of patients with chronic kidney disease. (2014) (71)
- Differential loss of fat and lean mass in the morbidly obese after bariatric surgery. (2010) (70)
- Potassium Homeostasis in Health and Disease: A Scientific Workshop Cosponsored by the National Kidney Foundation and the American Society of Hypertension. (2017) (69)
- Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19). (2020) (68)
- Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction (2020) (68)
- Gray zone BNP levels in heart failure patients in the emergency department: results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study. (2006) (67)
- The Effects of SGLT2 Inhibitors on Cardiovascular and Renal Outcomes in Diabetic Patients: A Systematic Review and Meta-Analysis (2019) (67)
- Cardiorenal syndrome type 3: pathophysiologic and epidemiologic considerations. (2013) (67)
- Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004. (2008) (66)
- The deadly triangle of anemia, renal insufficiency, and cardiovascular disease: implications for prognosis and treatment. (2005) (65)
- Proposal for a functional classification system of heart failure in patients with end-stage renal disease: proceedings of the acute dialysis quality initiative (ADQI) XI workgroup. (2014) (64)
- Effects of Intra-Arterial and Intravenous Iso-Osmolar Contrast Medium (Iodixanol) on the Risk of Contrast-Induced Acute Kidney Injury: A Meta-Analysis (2011) (63)
- Pathophysiology of the Cardiorenal Syndromes: Executive Summary from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) (2014) (63)
- Intensive Hemodialysis and Treatment Complications and Tolerability. (2016) (62)
- Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents (2018) (62)
- Cardiorespiratory fitness and obstructive sleep apnea syndrome in morbidly obese patients. (2008) (62)
- Current Risk of Contrast-Induced Acute Kidney Injury After Coronary Angiography and Intervention: A Reappraisal of the Literature. (2017) (61)
- Cardiorenal syndrome type 4: insights on clinical presentation and pathophysiology from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). (2013) (61)
- Current and future challenges in therapy for antibody-mediated rejection. (2011) (60)
- Mortality benefit of angiotensin-converting enzyme inhibitors after cardiac events in patients with end-stage renal disease (2002) (60)
- Subclinical acute kidney injury (AKI) due to iodine-based contrast media (2013) (60)
- Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis. (2021) (60)
- Etiology and pathophysiology of new-onset heart failure: Evaluation by myocardial perfusion imaging (2009) (59)
- Impact of treating the metabolic syndrome on chronic kidney disease (2009) (59)
- No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease. (2013) (57)
- Acute Kidney Injury and Cardiovascular Outcomes in Acute Severe Hypertension (2010) (57)
- Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP). (2008) (57)
- Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial (2014) (57)
- Bundle branch block patterns, age, renal dysfunction, and heart failure mortality. (2005) (56)
- Kidney early evaluation program: a community-based screening approach to address disparities in chronic kidney disease. (2010) (56)
- The relationship between B-type natriuretic peptide and health status in patients with heart failure. (2005) (56)
- Reducing Contrast-Induced Acute Kidney Injury Using a Regional Multicenter Quality Improvement Intervention (2014) (56)
- SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically ill (2020) (56)
- The prognostic significance of serial myoglobin, troponin I, and creatine kinase-MB measurements in patients evaluated in the emergency department for acute coronary syndrome. (2003) (56)
- Awareness of kidney disease and relationship to end-stage renal disease and mortality. (2012) (56)
- Effect of Gastric Bypass on Vitamin D and Secondary Hyperparathyroidism (2010) (55)
- Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP). (2013) (55)
- Delays in Presentation in Patients With Acute Myocardial Infarction During the COVID-19 Pandemic (2020) (54)
- Cardiorenal syndromes. (2011) (53)
- Cardiorespiratory Fitness and Sedentary Lifestyle in the Morbidly Obese (2009) (53)
- Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis Study. (2016) (52)
- Performance of multiple cardiac biomarkers measured in the emergency department in patients with chronic kidney disease and chest pain. (2002) (52)
- Impact of obesity on cardiovascular disease. (2008) (52)
- Kinetics of Urinary Cell Cycle Arrest Markers for Acute Kidney Injury Following Exposure to Potential Renal Insults (2017) (51)
- Obesity and lipids (2005) (51)
- The independent association of renal dysfunction and arrhythmias in critically ill patients. (2002) (50)
- Phidippides Cardiomyopathy: A Review and Case Illustration (2012) (50)
- Cardiorespiratory fitness: an independent and additive marker of risk stratification and health outcomes. (2009) (49)
- The Central Role of Endothelial Dysfunction in Cardiorenal Syndrome (2016) (49)
- Cardiovascular Disease in Chronic Kidney Disease: Data from the Kidney Early Evaluation Program (KEEP) (2011) (48)
- National Kidney Foundation's Kidney Early Evaluation Program (KEEP) annual data report 2009: executive summary. (2010) (48)
- Association between lack of health insurance and risk of death and ESRD: results from the Kidney Early Evaluation Program (KEEP). (2013) (48)
- Perception of indications for nephrology referral among internal medicine residents: a national online survey. (2009) (48)
- Beyond serum creatinine: defining the patient with renal insufficiency and why? (2003) (47)
- The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management. (2008) (46)
- Loop diuretics in acute heart failure: beyond the decongestive relief for the kidney (2015) (46)
- Chronic Kidney Disease and Sudden Death: Strategies for Prevention (2004) (46)
- Piecing together the evidence on anemia: the link between chronic kidney disease and cardiovascular disease. (2005) (45)
- CKD awareness in the United States: the Kidney Early Evaluation Program (KEEP). (2008) (45)
- Cardio-renal syndrome type 1: epidemiology, pathophysiology, and treatment. (2012) (45)
- Bioimpedance-Guided Hydration for the Prevention of Contrast-Induced Kidney Injury: The HYDRA Study. (2018) (44)
- Relation among body mass index, exercise training, and outcomes in chronic systolic heart failure. (2011) (44)
- Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). (2013) (43)
- Prevalence of Hyperuricemia in Patients With Acute Heart Failure With Either Reduced or Preserved Ejection Fraction. (2017) (43)
- Length of stay and procedure utilization are the major determinants of hospital charges for heart failure (2001) (42)
- Cardiorenal Syndromes: Pathophysiology to Prevention (2010) (42)
- How do centres begin the process to prevent contrast-induced acute kidney injury: a report from a new regional collaborative (2011) (41)
- Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs (2022) (41)
- Cardiovascular disease and the kidney (2002) (41)
- Changes in B-type natriuretic peptide levels in hemodialysis and the effect of depressed left ventricular function. (2005) (41)
- Doppler‐Derived Renal Venous Stasis Index in the Prognosis of Right Heart Failure (2019) (40)
- Contrast-induced nephropathy: Clinical insights and practical guidance - A report from the CIN Consensus Working Panel - Overview (2006) (40)
- Underuse of invasive procedures among Medicaid patients with acute myocardial infarction. (2001) (40)
- Cardiac natriuretic peptides:a proteomic window to cardiac function and clinical management. (2003) (39)
- Outcomes and prognostic factors of systolic as compared with diastolic heart failure in urban America. (2005) (39)
- Serum catalytic iron as a novel biomarker of vascular injury in acute coronary syndromes. (2009) (39)
- Emergency evaluation of chest pain in patients with advanced kidney disease. (2002) (39)
- Hyperthyroidism: a "curable" cause of congestive heart failure--three case reports and a review of the literature. (2003) (39)
- Prognostic Significance of Hyperuricemia in Patients With Acute Heart Failure. (2016) (39)
- Cardiorespiratory Fitness: An Independent and Additive Marker of Risk Stratification and Health Outcomes (2009) (39)
- Access to health care among adults evaluated for CKD: findings from the Kidney Early Evaluation Program (KEEP). (2012) (39)
- ADQI 7: the clinical management of the Cardio-Renal syndromes: work group statements from the 7th ADQI consensus conference. (2010) (38)
- Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection. (2020) (38)
- Intensive Hemodialysis, Blood Pressure, and Antihypertensive Medication Use. (2016) (38)
- Albuminuria and Renal Function in Obese Adults Evaluated for Obstructive Sleep Apnea (2009) (38)
- Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: prevalence of and risk factors for diabetes mellitus in CKD in the Kidney Early Evaluation Program (KEEP). (2011) (38)
- PET perfusion and vasodilator function after angioplasty for acute myocardial infarction. (1997) (37)
- Role of Angiotensin II in the Evolution of Diastolic Heart Failure (2005) (37)
- High-risk situations and procedures. (2006) (37)
- Pre-procedural bioimpedance vectorial analysis of fluid status and prediction of contrast-induced acute kidney injury. (2014) (37)
- Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use. (2016) (37)
- ApoCIII as a Cardiovascular Risk Factor and Modulation by the Novel Lipid-Lowering Agent Volanesorsen (2017) (36)
- Primer: practical approach to the selection of patients for and application of EECP (2006) (36)
- Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP). (2013) (36)
- Outcomes of patients considered for, but not admitted to, the intensive care unit* (2008) (36)
- The Big Mush: Psychometric Measures are Confounded and Non-Independent in Their Association with Age at Initial Diagnosis of Ischaemic Coronary Heart Disease (2002) (36)
- Costs and outcomes of patients admitted with chest pain and essentially normal electrocardiograms (1998) (36)
- Association between serum resistin and carotid intima media thickness in hypertension patients. (2008) (36)
- Cardiorenal Outcomes in the CANVAS, DECLARE-TIMI 58, and EMPA-REG OUTCOME Trials: A Systematic Review. (2018) (36)
- Heart Failure in End-Stage Kidney Disease: Pathophysiology, Diagnosis, and Therapeutic Strategies. (2018) (35)
- Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia. (2015) (35)
- Cardiac and Renal Fibrosis in Chronic Cardiorenal Syndromes (2014) (35)
- Patient Discomfort Associated with the Use of Intra-arterial Iodinated Contrast Media: A Meta-Analysis of Comparative Randomized Controlled Trials (2011) (34)
- Prediction of death and neurologic outcome in the emergency department in out-of-hospital cardiac arrest survivors. (1998) (34)
- Cardiovascular calcification in patients with chronic renal failure: are we on target with this risk factor? (2004) (34)
- Prevalence and Prognosis of Hyperkalemia in Patients with Acute Myocardial Infarction. (2016) (34)
- Lipoic Acid in the Prevention of Acute Kidney Injury (2016) (34)
- Amplification of atherosclerotic calcification and Mönckeberg's sclerosis: a spectrum of the same disease process. (2008) (34)
- Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. (2010) (33)
- ADQI consensus on AKI biomarkers and cardiorenal syndromes (2013) (33)
- Application of a cardiac arrest score in patients with sudden death and ST segment elevation for triage to angiography and intervention. (2002) (33)
- Kidney attack versus heart attack: evolution of classification and diagnostic criteria (2013) (33)
- Validity of Estimated Glomerular Filtration Rates for Assessment of Baseline and Serial Renal Function in Patients With Atherosclerotic Renal Artery Stenosis: Implications for Clinical Trials of Renal Revascularization (2011) (33)
- The RANTES -403G>A promoter polymorphism in Korean men: association with serum RANTES concentration and coronary artery disease. (2007) (33)
- Neutrophil Gelatinase-Associated Lipocalin: A Novel Marker of Contrast Nephropathy Risk (2012) (33)
- Cardiorenal Interaction: Appropriate Treatment of Cardiovascular Risk Factors to Improve Outcomes in Chronic Kidney Disease (2010) (33)
- A Call to Action to Develop Integrated Curricula in Cardiorenal Medicine (2017) (32)
- What is in the differential diagnosis of a B-type natriuretic peptide level of 1,000 pg/ml? (2003) (32)
- Associations between access to care and awareness of CKD. (2012) (32)
- ABT‐719 for the Prevention of Acute Kidney Injury in Patients Undergoing High‐Risk Cardiac Surgery: A Randomized Phase 2b Clinical Trial (2016) (32)
- Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study. (2006) (31)
- Perioperative THR-184 and AKI after Cardiac Surgery. (2017) (31)
- Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion. (2016) (31)
- Potassium homeostasis in health and disease: A scientific workshop cosponsored by the National Kidney Foundation and the American Society of Hypertension. (2017) (31)
- Hyperacute drug-induced hepatitis with intravenous amiodarone: case report and review of the literature (2013) (30)
- Chapter 1: Introduction and definition of CKD-MBD and the development of the guideline statements. (2009) (30)
- Effect of lipid modification on progression of coronary calcification. (2005) (30)
- Dysglycemia Predicts Cardiovascular and Kidney Disease in the Kidney Early Evaluation Program (2010) (30)
- Anemia and Associated Clinical Outcomes in Patients With Heart Failure Due to Reduced Left Ventricular Systolic Function (2013) (30)
- Timing of angiography and revascularization in acute coronary syndromes: an analysis of the TACTICS-TIMI-18 trial. (2004) (30)
- Lower Than Predicted Resting Metabolic Rate Is Associated With Severely Impaired Cardiorespiratory Fitness in Obese Individuals (2012) (30)
- Asthma, beta-agonists, and development of congestive heart failure: results of the ABCHF study. (2002) (30)
- Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study (2017) (30)
- Improved noninvasive coronary angiography in morbidly obese patients with dual-source computed tomography. (2009) (29)
- Obesity is associated with increased parathyroid hormone levels independent of glomerular filtration rate in chronic kidney disease. (2010) (29)
- Vitamin D deficiency in association with endothelial dysfunction: Implications for patients with COVID-19. (2020) (29)
- Myocardial Ischemia in Patients with Diastolic Dysfunction and Heart Failure (2010) (29)
- Effects of sodium glucose co-transporter 2 inhibitors on the kidney (2018) (29)
- Inhibition of the Sodium-Proton Antiporter (Exchanger) is a Plausible Mechanism of Potential Benefit and Harm for Drugs Designed to Block Sodium Glucose Co-transporter 2. (2018) (29)
- Physician utilization, risk-factor control, and CKD progression among participants in the Kidney Early Evaluation Program (KEEP). (2012) (29)
- Hypertension in early-stage kidney disease: an update from the Kidney Early Evaluation Program (KEEP). (2009) (29)
- Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study (2020) (28)
- Lipoprotein-associated phospholipase A2: role in atherosclerosis and utility as a cardiovascular biomarker (2010) (27)
- Preventing Weight Regain After Bariatric Surgery: An Overview of Lifestyle and Psychosocial Modulators (2010) (27)
- Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection. (2020) (27)
- Malignant hypertension presenting as hemolysis, thrombocytopenia, and renal failure. (2003) (27)
- Sustainable community-based CKD screening methods employed by the National Kidney Foundation's Kidney Early Evaluation Program (KEEP). (2011) (26)
- The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea: an analysis from the Breathing Not Properly Multinational Study. (2004) (26)
- Practical experience using galectin-3 in heart failure (2014) (26)
- Slowing the progression of diabetic nephropathy and its cardiovascular consequences. (2004) (26)
- Impact of Reduced Kidney Function on Cardiopulmonary Fitness in Patients with Systolic Heart Failure (2010) (26)
- Randomized Controlled Trials of Early Ambulatory Hydroxychloroquine in the Prevention of COVID-19 Infection, Hospitalization, and Death: Meta-Analysis (2020) (25)
- Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study (2015) (25)
- Multimodality prevention of contrast-induced acute kidney injury. (2008) (25)
- Serum cystatin C, renal filtration function, and left ventricular remodeling. (2009) (25)
- Evaluation and treatment of coronary artery disease in patients with end-stage renal disease. (2005) (25)
- Central versus local adjudication of myocardial infarction in a cardiac biomarker trial. (2013) (24)
- Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy. (2001) (24)
- Treatment of Severe Metastatic Calcification and Calciphylaxis in Dialysis Patients (2011) (24)
- Novel Agents for the Prevention and Management of Hyperkalemia. (2015) (24)
- Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis (2020) (23)
- Bariatric surgery for morbid obesity: risks and benefits in chronic kidney disease patients. (2006) (23)
- Racial differences in kidney function among individuals with obesity and metabolic syndrome: results from the Kidney Early Evaluation Program (KEEP). (2010) (23)
- Coronary Calcification and Cardiac Events after Percutaneous Intervention in Dialysis Patients (2001) (23)
- Review article: Risks of coronary artery calcification in chronic kidney disease: Do the same rules apply? (2009) (23)
- Identification and Management of Chronic Kidney Disease Complications by Internal Medicine Residents: A National Survey (2011) (23)
- Mortality Risk Assessment Using CHA(2)DS(2)-VASc Scores in Patients Hospitalized With Coronavirus Disease 2019 Infection (2020) (23)
- Acute and chronic cardiovascular effects of hyperkalemia: new insights into prevention and clinical management. (2014) (23)
- Treatment of hypertriglyceridemia with fibric acid derivatives: impact on lipid subfractions and translation into a reduction in cardiovascular events. (2011) (23)
- Antecedent Administration of Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID‐19 Syndrome (2020) (22)
- Urine Catalytic Iron and Neutrophil Gelatinase-Associated Lipocalin as Companion Early Markers of Acute Kidney Injury after Cardiac Surgery: A Prospective Pilot Study (2013) (22)
- Gestational Diabetes Mellitus Alone in the Absence of Subsequent Diabetes Is Associated With Microalbuminuria (2010) (22)
- Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease. (2019) (22)
- Gestational diabetes alone , in the absence of subsequent diabetes , is associated with microalbuminuria : results from the Kidney Early Evaluation Program ( KEEP ) (2010) (21)
- Prediction and prevention of contrast nephropathy. (2001) (21)
- Ventricular Fibrillation Storm in Coronavirus 2019 (2020) (21)
- B-type natriuretic peptides. A diagnostic breakthrough in heart failure. (2003) (21)
- Acute coronary syndromes in patients with renal failure (2003) (21)
- Benefits and Risks of Continuing Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Antagonists, and Mineralocorticoid Receptor Antagonists during Hospitalizations for Acute Heart Failure (2020) (21)
- A Review of the Use of Iloprost, A Synthetic Prostacyclin, in the Prevention of Radiocontrast Nephropathy in Patients Undergoing Coronary Angiography and Intervention (2015) (21)
- Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials). (2018) (20)
- Peak oxygen consumption and the minute ventilation/carbon dioxide production relation slope in morbidly obese men and women: influence of subject effort and body mass index. (2008) (19)
- Cardionephrology: Proposal for a Futuristic Educational Approach to a Contemporary Need (2018) (19)
- Diabetic Cardiovascular Disease Predicts Chronic Kidney Disease Awareness in the Kidney Early Evaluation Program (2011) (19)
- Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro. (2016) (19)
- Alteration of lipid metabolism in chronic kidney disease, the role of novel antihyperlipidemic agents, and future directions. (2018) (19)
- Cardiovascular Disease in Patients with Chronic Kidney Disease (2019) (19)
- Major Adverse Renal and Cardiac Events After Coronary Angiography and Cardiac Surgery. (2018) (19)
- Favipiravir and the Need for Early Ambulatory Treatment of SARS-CoV-2 Infection (COVID-19) (2020) (19)
- Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro. (2016) (19)
- Prostaglandin-based renal protection against contrast-induced acute kidney injury. (2009) (18)
- Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19 (2021) (18)
- Initial Data Report from LARIAT: A Phase 2 Study of Bardoxolone Methyl in PAH Patients on Stable Background Therapy (2015) (18)
- Hyperuricemia and Cardiovascular Disease. (2017) (18)
- Fulminant Acute Kidney Injury in a Young Patient with Novel Coronavirus 2019 (2020) (18)
- Darapladib and atherosclerotic plaque: Should lipoprotein-associated phospholipase A2 be a therapeutic target? (2009) (18)
- the American Heart Association Bariatric Surgery and Cardiovascular Risk Factors: A Scientific Statement From (2011) (18)
- Validation of a decision support tool for the evaluation of cardiac arrest victims (1998) (18)
- Development and Initial Validation of the PROMIS®-Plus-HF Profile Measure. (2019) (17)
- New vistas for the treatment of obesity: turning the tide against the leading cause of morbidity and cardiovascular mortality in the developed world. (2013) (17)
- Advances in CKD detection and determination of prognosis: executive summary of the National Kidney Foundation-Kidney Early Evaluation Program (KEEP) 2012 annual data report. (2013) (17)
- Failure of beta-blockers in the reduction of perioperative events: where did we go wrong? (2006) (17)
- Meta-analysis of outcomes of patients with COVID-19 infection with versus without gastrointestinal symptoms (2020) (17)
- Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19 (2021) (17)
- Coronary artery disease. (2007) (17)
- Influence of Chronic Renal Failure on Cardiac Structure. (2016) (17)
- How Trialists and Pharmaceutical Sponsors Have Failed Us by Thinking That Acute Heart Failure Is a 48-Hour Illness. (2017) (17)
- Preeclampsia as a Form of Type 5 Cardiorenal Syndrome: An Underrecognized Entity in Women’s Cardiovascular Health (2018) (17)
- Impact of body mass index on outcomes of enhanced external counterpulsation therapy. (2006) (17)
- Comparative Efficacy of Transradial Versus Transfemoral Approach for Coronary Angiography and Percutaneous Coronary Intervention. (2016) (16)
- Management of gastrointestinal bleeding in patients anticoagulated with dabigatran compared with warfarin: a retrospective, comparative case review. (2014) (16)
- Scope of cardiovascular complications in patients with kidney disease. (2002) (16)
- Contrast induced acute kidney injury in interventional cardiology: an update and key guidance for clinicians. (2020) (16)
- In-Hospital Mortality and Major Adverse Cardiovascular Events after Kidney Transplantation in the United States (2018) (16)
- Anemia of cardiorenal syndrome. (2021) (16)
- Chronic kidney disease from screening, detection, and awareness, to prevention. (2016) (15)
- Comprehensive Review of the Relative Clinical Utility of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide Assays in Cardiovascular Disease (2009) (15)
- What is the Ideal Blood Pressure Goal for Patients with Stage III or Higher Chronic Kidney Disease? (2011) (15)
- Anemia: a modifiable risk factor for heart disease. Introduction. (2005) (15)
- Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients (2021) (15)
- Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO2VATE trials (2020) (15)
- Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy (2018) (15)
- Interpreting the Wide Range of NT-proBNP Concentrations in Clinical Decision Making. (2018) (15)
- Continuation of Chronic Heart Failure Therapies During Heart Failure Hospitalization - a Review. (2019) (15)
- Opportunities for improvement in the diagnosis and treatment of heart failure (2003) (15)
- Kidney disease in heart failure: the importance of novel biomarkers for type 1 cardio-renal syndrome detection (2015) (15)
- Coronary revascularization in patients with end-stage renal disease: risks, benefits, and optimal strategies. (2003) (15)
- Lipids, biomarkers, and noninvasive imaging of atherosclerotic disease activity in clinical trials. (2008) (14)
- Resuscitation for the specialty of nephrology: is cardionephrology the answer? (2018) (14)
- Nutritional and micronutrient determinants of idiopathic dilated cardiomyopathy: diagnostic and therapeutic implications (2011) (14)
- An evidence-based algorithm for the use of B-type natriuretic testing in acute coronary syndromes. (2010) (14)
- The Role of Dendritic and Endothelial Cells in Cardiorenal Syndrome (2018) (14)
- Admission hyperglycemia and length of hospital stay in patients with diabetes and heart failure: a prospective cohort study. (2008) (14)
- Statin therapy in renal disease: Harmful or protective? (2007) (14)
- National Kidney Foundation's Kidney Early Evaluation Program (KEEP) annual data report 2011: executive summary. (2012) (13)
- Urinary 11-Dehydro-Thromboxane B2 and Mortality in Patients With Stable Coronary Artery Disease. (2017) (13)
- The efficacy and safety of enhanced external counterpulsation in patients with peripheral arterial disease (2010) (13)
- The Association between Parathyroid Hormone Levels and the Cardiorenal Metabolic Syndrome in Non-Diabetic Chronic Kidney Disease (2011) (13)
- Beside B-type natriuretic peptide in the emergency diagnosis of systolic and nonsystolic heart failure: Results from the breathing not properly (BNP) multinational study (2003) (13)
- Evaluation of narrative text for case finding: the need for accuracy measurement. (1998) (13)
- Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness (2019) (13)
- Management of coronary atherosclerosis and acute coronary syndromes in patients with chronic kidney disease. (2013) (13)
- Novel markers and therapies for patients with acute heart failure and renal dysfunction. (2015) (13)
- Six-Month Outcomes for COVID-19 Negative Patients with Acute Myocardial Infarction Before Versus During the COVID-19 Pandemic (2021) (13)
- National Kidney Foundation's Kidney Early Evaluation Program (KEEP) annual data report 2010: executive summary. (2011) (12)
- Interface Between Renal Disease and Cardiovascular Illness (2012) (12)
- Coronary Artery Plaque and Cardiotoxicity as a Result of Extreme Endurance Exercise. (2014) (12)
- Usefulness of alirocumab and evolocumab for the treatment of patients with diabetic dyslipidemia (2018) (12)
- Frequency of Fluid Overload and Usefulness of Bioimpedance in Patients Requiring Intensive Care for Sepsis Syndromes (2016) (12)
- Usefulness of Oral Ferric Citrate in Patients With Iron-Deficiency Anemia and Chronic Kidney Disease With or Without Heart Failure. (2018) (12)
- Clinical applications of B-type natriuretic peptide levels in the care of cardiovascular patients. (2004) (12)
- Clinical Impact of Changes in Hemodynamic Indices of Contractile Function During Treatment of Acute Decompensated Heart Failure. (2018) (12)
- Renal safety of iodixanol (2006) (11)
- Renal Function and Scaled Troponin in Patients Presenting to the Emergency Department with Symptoms of Myocardial Infarction (2017) (11)
- Contribution of ApoCIII to Diabetic Dyslipidemia and Treatment With Volanesorsen. (2018) (11)
- Kidney's role in hypertension. (2009) (11)
- Shorter circular staple is height associated with lower anastomotic stricture rate in laparoscopic gastric bypass. (2012) (11)
- Endothelial Nitric Oxide Synthase Glu298Asp Gene Polymorphism is Associated with Hypertensive Response to Exercise in Well-Controlled Hypertensive Patients (2007) (11)
- Minimizing the renal toxicity of iodinated contrast. (2011) (11)
- Cardiorespiratory fitness and sleep-related breathing disorders (2008) (11)
- Cardiac and renal function in patients with type 2 diabetes who have chronic kidney disease: potential effects of bardoxolone methyl (2012) (11)
- Impact of obesity on the health status of heart failure patients. (2006) (11)
- Antihypertensive drugs and risk of COVID-19? (2020) (11)
- Early detection of acute kidney injury with neutrophil gelatinase-associated lipocalin. (2011) (11)
- Contrast-Induced Nephropathy: Definitions, Epidemiology, and Implications. (2014) (11)
- Treatment disparities in acute coronary syndromes, heart failure, and kidney disease. (2011) (11)
- Prevention of cardiorenal syndromes. (2010) (11)
- WITHDRAWN: A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products (2021) (11)
- Clinical impact of renal dysfunction in heart failure. (2011) (11)
- Subclinical coronary atherosclerosis identified by coronary computed tomographic angiography in asymptomatic morbidly obese patients (2010) (11)
- Renal and Cardiovascular Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes and Chronic Kidney Disease: Perspectives on the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation Trial Results (2020) (10)
- Volume expansion and contrast-induced acute kidney injury (2017) (10)
- Questionnaire instrument to assess knowledge of chronic kidney disease clinical practice guidelines among internal medicine residents. (2009) (10)
- Effect of enhanced external counterpulsation on resting oxygen uptake in patients having previous coronary revascularization and in healthy volunteers. (2006) (10)
- The association of parathyroid hormone with ESRD and pre-ESRD mortality in the Kidney Early Evaluation Program. (2012) (10)
- B-type natriuretic peptide and its clinical implications in heart failure. (2004) (10)
- Dysglycemia but not lipids is associated with abnormal urinary albumin excretion in diabetic kidney disease: a report from the Kidney Early Evaluation Program (KEEP) (2012) (10)
- Contemporary practice patterns related to the risk of acute kidney injury in the catheterization laboratory: Results from a survey of Society of Cardiovascular Angiography and Intervention (SCAI) cardiologists (2017) (10)
- Ascorbic acid for the prevention of contrast-induced acute kidney injury. (2013) (10)
- Appendix 1: 10th Acute Dialysis Quality Initiative (ADQI) Consensus Group (2013) (10)
- The Association between Parathyroid Hormone Levels and Hemoglobin in Diabetic and Nondiabetic Participants in the National Kidney Foundationʼs Kidney Early Evaluation Program (2013) (10)
- The role of early and sufficient isolated venovenous ultrafiltration in heart failure patients with pulmonary and systemic congestion. (2013) (10)
- Point-of-Care, Ultraportable Echocardiography Predicts Diuretic Response in Patients Admitted with Acute Decompensated Heart Failure (2016) (10)
- Contrast-induced acute kidney injury in renal transplant recipients after cardiac catheterization. (2009) (10)
- Blood B-Type Natriuretic Peptide and Dialysis: Present Assessment and Future Analyses (2008) (10)
- Understanding and Managing Atrial Fibrillation in Patients with Kidney Disease. (2015) (10)
- Natriuretic peptides in the prognosis and management of acute coronary syndromes. (2010) (10)
- Differential diagnosis and overlap of acute chest discomfort and dyspnea in the emergency department. (2010) (9)
- Association of physician care with mortality in Kidney Early Evaluation Program (KEEP) participants. (2012) (9)
- Opportunities for improvement in the cardiovascular care of patients with end-stage renal disease. (2004) (9)
- Cardiorenal syndromes in critical care (2010) (9)
- The effect of major adverse renal cardiovascular event (MARCE) incidence, procedure volume, and unit cost on the hospital savings resulting from contrast media use in inpatient angioplasty (2018) (9)
- Fatal case of delayed repolarization due to cocaine abuse and global ischemia. (2003) (9)
- Plasma Volume and Renal Function Predict Six-Month Survival after Hospitalization for Acute Decompensated Heart Failure (2017) (9)
- Balancing Low-density Lipoprotein Cholesterol Reduction and Hepatotoxicity With Lomitapide Mesylate and Mipomersen in Patients With Homozygous Familial Hypercholesterolemia. (2017) (9)
- Pathophysiological Crosstalk Leading to Combined Heart and Kidney Dysfunction in the Setting of Acutely Decompensated Heart Failure (2012) (9)
- Real or Perceived: Hyperkalemia Is a Major Deterrent for Renin-Angiotensin Aldosterone System Inhibition in Heart Failure (2017) (9)
- COVID-19-Associated Systemic Thromboembolism: A Case Report and Review of the Literature (2020) (9)
- Substantial weight gain during adulthood: the road to bariatric surgery. (2005) (9)
- Cardiovascular outcomes and renal disease. (2002) (9)
- Chronic kidney disease as a risk factor for acute coronary syndromes in patients presenting to the emergency room with chest pain. (2012) (9)
- Type 4 Cardiorenal Syndrome: Myocardial Dysfunction, Fibrosis, and Heart Failure in Patients with Chronic Kidney Disease (2012) (9)
- Rapid bedside coronary angiography with a portable fluoroscopic imaging system. (1997) (9)
- Diagnosis of Cardiovascular Disease in Patients with Chronic Kidney Disease (2012) (9)
- Nomenclature in nephrology: preserving ‘renal’ and ‘nephro' in the glossary of kidney health and disease (2021) (9)
- Considerations for Management of Acute Coronary Syndromes During the SARS-CoV-2 (COVID-19) Pandemic (2020) (9)
- What causes elevated B-type natriuretic peptide in patients without heart failure? (2003) (9)
- Utilization of galectin-3 in case management across the spectrum of heart failure. (2014) (9)
- Cardiovascular outcomes in diabetic kidney disease: insights from recent clinical trials. (2018) (9)
- Subarachnoid hemorrhage with neurocardiogenic stunning. (2010) (9)
- Iso-osmolar contrast media and adverse renal and cardiac events after percutaneous cardiovascular intervention. (2018) (9)
- Determinants of markedly increased B-type natriuretic peptide in patients with ST-segment elevation myocardial infarction. (2011) (9)
- Optimizing outcomes in coronary CT imaging. (2008) (9)
- Impact of Durable Ventricular Assist Device Support on Outcomes of Patients with Congenital Heart Disease Waiting for Heart Transplant (2020) (8)
- Aging Male Spontaneously Hypertensive Rat as an Animal Model for the Evaluation of the Interplay between Contrast-Induced Acute Kidney Injury and Cardiorenal Syndrome in Humans (2016) (8)
- Body weight limitations of United States cardiac catheterization laboratories including restricted access for the morbidly obese. (2008) (8)
- The management of acute coronary syndromes in patients with chronic kidney disease. (2014) (8)
- Statins for the Prevention of Contrast-Induced Acute Kidney Injury (2014) (8)
- Micronutrients and Cardiorenal Disease: Insights into Novel Assessments and Treatment (2011) (8)
- Statins for the Prevention of Contrast-Induced Acute Kidney Injury (2014) (8)
- Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea. (2009) (8)
- Cardiovascular Risk Reduction in Patients With Chronic Kidney Disease: Potential for Targeting Inflammation With Canakinumab. (2018) (8)
- Oxidative stress reflected by increased F2-isoprostanes is associated with increasing urinary 11-dehydro thromboxane B2 levels in patients with coronary artery disease. (2016) (8)
- Residual thromboxane activity and oxidative stress: influence on mortality in patients with stable coronary artery disease (2017) (8)
- Residual high-grade angina after enhanced external counterpulsation therapy. (2007) (8)
- Treating type 2 diabetes: incretin mimetics and enhancers (2009) (8)
- A prospective, randomized placebo-controlled multicenter trial evaluating fenoldopam mesylate for the prevention of contrast induced nephropathy: The CONTRAST trial (2003) (8)
- Chronic kidney disease: tipping the scale to the benefit of angiotensin-converting enzyme inhibitors in patients with coronary artery disease. (2006) (8)
- The emerging role of brain natriuretic peptide in the management of acute and chronic heart failure in outpatients. (2003) (8)
- Nutritional Deficiencies and Sarcopenia in Heart Failure: A Therapeutic Opportunity to Reduce Hospitalization and Death. (2016) (8)
- Cardiovascular risk modification in participants with coronary disease screened by the Kidney Early Evaluation Program (2010) (8)
- A decade after the KDOQI CKD guidelines: impact on the National Kidney Foundation's Kidney Early Evaluation Program (KEEP). (2012) (8)
- A time-to-treatment analysis in the medicine versus angiography in thrombolytic exclusion (MATE) trial. (2001) (8)
- Influence of myocardial ischemia on outcomes in patients with systolic versus non-systolic heart failure. (2011) (7)
- Executive summary: Kidney Early Evaluation Program (KEEP) 2008 annual data report. (2009) (7)
- Acute contrast nephropathy after coronary intervention: Incidence, risk factors, and relationship to mortality (1996) (7)
- Atypical Presentation of Cocaine-induced Type A Aortic Dissection: A Diagnosis Made by Transesophageal Echocardiography (2002) (7)
- Focus on Lipids: High-Density Lipoprotein Cholesterol and Its Associated Lipoproteins in Cardiac and Renal Disease (2014) (7)
- Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents (2021) (7)
- The CatLet score: a new coronary angiographic scoring tool accommodating the variable coronary anatomy for the first time. (2019) (7)
- B-Type Natriuretic Peptide: Beyond Diagnostic Applications (2012) (7)
- Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension (2005) (7)
- The rosiglitazone meta-analysis. (2007) (7)
- Influence of regional cardiovascular mortality on the use of angiography after acute myocardial infarction. (1997) (7)
- Mortality and guideline‐directed medical therapy in real‐world heart failure patients with reduced ejection fraction (2021) (7)
- A Lethal Case of Influenza and Type 5 Cardiorenal Syndrome (2013) (7)
- Treatment disparities in patients with acute coronary syndromes and kidney disease. (2009) (7)
- Endothelial Cell Autoantibodies in Predicting Declining Renal Function, End-Stage Renal Disease, or Death in Adult Type 2 Diabetic Nephropathy (2014) (7)
- Focus on Lipids: High-Density Lipoprotein Cholesterol and Its Associated Lipoproteins in Cardiac and Renal Disease (2014) (7)
- Cardiorenal Nexus: A Review With Focus on Combined Chronic Heart and Kidney Failure, and Insights From Recent Clinical Trials (2022) (7)
- Understanding and Overcoming the Challenges Related to Cardiovascular Trials Involving Patients with Kidney Disease. (2021) (7)
- Personalized Treatment of Heart Failure with Biomarker Guidance Using a Novel Disease Severity Score (2017) (6)
- Cardiorenal Syndromes: Advances in Determining Diagnosis, Prognosis and Therapy (2015) (6)
- Advantages of group treatment and structured exercise in promoting short-term weight loss and cardiovascular risk reduction in adults with central obesity. (2009) (6)
- Key Updates in Cardio-Nephrology from 2018: Springboard to a Bright Future (2019) (6)
- Detection of Atherosclerotic Cardiovascular Disease in Patients with Advanced Chronic Kidney Disease in the Cardiology and Nephrology Communities (2018) (6)
- Contrast Nephropathy and Kidney Injury (2014) (6)
- Ximelagatran: a novel oral direct thrombin inhibitor for long-term anticoagulation. (2004) (6)
- Percutaneous left ventricular assist device in acute myocardial infarction and cardiogenic shock. (2005) (6)
- Community-Acquired Acute Kidney Injury as a Risk Factor of de novo Heart Failure Hospitalization (2019) (6)
- The current and future landscape of urinary thromboxane testing to evaluate atherothrombotic risk. (2014) (6)
- Cardiovascular care in end-stage renal disease. (2004) (6)
- Performance of crisis standards of care guidelines in a cohort of critically ill COVID-19 patients in the United States (2021) (6)
- Identifying suspected familial chylomicronemia syndrome (2018) (6)
- Renal function and anaemia in acute myocardial infarction. (2013) (6)
- The economic impact of clinically significant tricuspid regurgitation in a large, administrative claims database (2020) (6)
- Impact of the history of congestive heart failure on accuracy of BNP in the emergency diagnosis of heart failure: results from the breathing not properly (BNP) multinational study (2004) (6)
- Capturing the pathophysiology of acute coronary syndromes with circulating biomarkers. (2010) (6)
- Efficacy of Subcutaneous Versus Intravenous Administration of Furosemide in Patients With Worsening Heart Failure: The Devil Is in the Details. (2018) (6)
- Fibrates and cardiorenal outcomes. (2012) (6)
- B-type natriuretic peptide levels are inversely related to body mass index in patients with heart failure (2003) (6)
- Chronic angina: new medical options for treatment. (2005) (6)
- Impact of Short-Term Educational and Behavioral Therapy on Childhood Obesity (2008) (6)
- Personalized Treatment of Heart Failure with Biomarker Guidance Using a Novel Disease Severity Score (2017) (6)
- Alterations in Doppler-derived renal venous stasis index during recompensation of right heart failure and fluid overload in a patient with pulmonary hypertension. (2019) (6)
- Personalized Treatment of Heart Failure with Biomarker Guidance Using a Novel Disease Severity Score (2017) (6)
- Cardionephrology from the point of view of the cardiologist: no more agree to disagree—getting to ‘yes’ for every patient (2021) (5)
- Response to Cardiac Resynchronization Therapy Improves Renal Function. Importance of Forward and Backward Failure. (2009) (5)
- Effects of Bardoxolone Methyl on Magnesium in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease (2019) (5)
- Acute Kidney Injury After Carotid Artery Stenting. (2015) (5)
- Cardiovascular Safety and Efficacy of Vadadust for the Treatment of Anemia in Non-Dialysis Dependent CKD: Design and Baseline Characteristics. (2020) (5)
- Disconnect between community testing and hospitalization for SARS-CoV-2 (COVID-19) infection (2020) (5)
- The emerging role of natriuretic peptides in the diagnosis and treatment of decompensated heart failure (2004) (5)
- Dialysis fistulas and heart failure (2017) (5)
- Amiodarone prophylaxis for atrial fibrillation after cardiac surgery. (1998) (5)
- Cardiovascular risk reduction and preservation of renal function in the early nephropathy patient. (2004) (5)
- Cardiorenal intersection: crossroads to the future. (2007) (5)
- Editorial: contrast-induced acute kidney injury: shifting from elective to urgent coronary intervention. (2010) (5)
- Impact of mitral regurgitation on cardiovascular hospitalization and death in newly diagnosed heart failure patients (2020) (5)
- Semaglutide and GLP-1 analogues as weight-loss agents (2018) (5)
- Predictors of 30-day re-admissions in patients with infective endocarditis: a national population based cohort study. (2020) (5)
- Antecedent Administration of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for SARS‐CoV‐2 (COVID‐19) (2020) (5)
- B-type natriuretic peptide levels in patients in the emergency department with possible heart failure and previous stable angina pectoris and/or healed myocardial infarction. (2005) (5)
- Optimal dialysis for the end-stage renal disease patient with cardiovascular disease. (2004) (5)
- The antiinflammatory effects of statins. (2001) (5)
- Coronary revascularization in patients with coronary artery disease and chronic kidney disease. (2004) (5)
- SARS-CoV-2 infection and the COVID-19 pandemic: a call to action for therapy and interventions to resolve the crisis of hospitalization, death, and handle the aftermath. (2021) (5)
- Antiphospholipid syndrome with renal artery embolism: case report. (2002) (5)
- SELDI-TOF-MS Serum Profiling Reveals Predictors of Cardiac MRI Changes in Marathon Runners (2012) (5)
- Percutaneous coronary interventions in the high-risk renal patient: strategies for renal protection and vascular protection. (2005) (5)
- Prognostic value of urinary 11‐dehydro‐thromboxane B2 for mortality: A cohort study of stable coronary artery disease patients treated with aspirin (2018) (5)
- Controversies in vitamin D: deficiency and supplementation after Roux-en-Y gastric bypass surgery (2007) (5)
- New therapeutic agents for diabetic kidney disease (2008) (4)
- Improved symptoms, physical limitation, and self-efficacy after resynchronization in a patient with heart failure and a prolonged QRS duration. (2004) (4)
- Estimating Renal Filtration, Drug Dosing, and Clinical Outcomes. (2015) (4)
- Innovative Early Sequenced Multidrug Therapy for Sars-Cov-2 (Covid-19) Infection to Reduce Hospitalization and Death (2020) (4)
- Chronic anticoagulation in chronic kidney disease. (2014) (4)
- Chronic anticoagulation in chronic kidney disease. (2014) (4)
- Acute Kidney Injury in Heart Failure (2019) (4)
- Inpatient Mortality According to Level of Respiratory Support Received for Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Infection: A Prospective Multicenter Study (2020) (4)
- Spontaneous Coronary Artery Dissection: A Review of Pathogenesis, Presentations, Treatment, and Outcomes. (2017) (4)
- Audiocardiography in the cardiovascular evaluation of the morbidly obese (2010) (4)
- Use of microsomal triglyceride transfer protein inhibitors in patients with homozygous familial hypercholesterolemia: translating clinical trial experience into clinical practice. (2014) (4)
- The impact of systemic calcified atherosclerosis in patients with chronic kidney disease. (2008) (4)
- Screening, detection, and management of heart failure in the SARS-CoV2 (COVID-19) pandemic (2021) (4)
- Early use of coronary angiography and intervention. (1999) (4)
- Impact of Enhanced External Counterpulsation on Heart Failure Rehospitalization in Patients With Ischemic Cardiomyopathy. (2016) (4)
- Analysis of electrocardiographic intervals before and after transcatheter aortic valve implantation to predict the need for permanent pacing (2018) (4)
- Renal Function and Exercise Training in AmbulatoryHeart Failure Patients With a Reduced Ejection Fraction. (2018) (4)
- Role of endothelial cell receptors in the context of SARS-CoV-2 infection (COVID-19) (2021) (4)
- Relation Between Proprotein Convertase Subtilisin/Kexin Type 9 and Directly Measured Low-Density Lipoprotein Cholesterol (2017) (4)
- Analysis of electrocardiographic intervals before and after transcatheter aortic valve implantation to predict the need for permanent pacing (2018) (4)
- Mineralocorticoid receptor antagonists and mortality in heart failure with concurrent atrial fibrillation. (2012) (4)
- Screening, diagnosis, and management of CAD in asymptomatic diabetic patients. (2014) (4)
- Cardiovascular disease care fragmentation in kidney transplantation: a call for action. (2019) (4)
- Potassium Excretion and Outcomes in CKD: Is K Intake OK? (2017) (4)
- Impact of surgical and nonsurgical weight loss on diabetes resolution and cardiovascular risk reduction (2009) (4)
- Acute coronary syndromes in the peri‐operative period after kidney transplantation in United States (2020) (4)
- New vistas for the treatment of obesity: turning the tide against the leading cause of morbidity and cardiovascular mortality in the developed world. (2014) (4)
- Interface between heart disease and renal dysfunction: from association to action (2003) (4)
- Does quality of life evidence assist in the selection of patients for resynchronization therapy? (2003) (4)
- Aspirin and Ticlopidine After Routine Coronary Stenting: The Gold Standard as of 1999 (1999) (4)
- Measuring the Variation in the Prevention and Treatment of CI-AKI Among Interventional Cardiologists. (2021) (4)
- Clinical Resolution of Type 2 Diabetes with Reduction in Body Mass Index Using Meal Replacement Based Weight Loss (2008) (4)
- Impact of an Educational Program for Advanced Practice Nurses on Knowledge of Kidney Disease Outcomes Quality Initiative Guidelines. (2015) (4)
- Early multidrug regimens in new potentially fatal medical problems. (2020) (3)
- Lipoproteins, inflammatory biomarkers, and cardiovascular imaging in the assessment of atherosclerotic disease activity. (2009) (3)
- Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failure (2021) (3)
- Lipoprotein subfractions and particle size in end-stage renal disease. (2011) (3)
- First and recurrent events after percutaneous coronary intervention: implications for survival analyses (2019) (3)
- Guest editorial: cardiovascular care in end-stage renal disease (2004) (3)
- Atrophy of the Heart After Insertion of a Left Ventricular Assist Device and Closure of the Aortic Valve. (2016) (3)
- Best of the AHA Scientific Sessions 2009 (2009) (3)
- Frequency of abnormal fractional flow reserve measurements among major coronary arteries. (2019) (3)
- B-type natriuretic peptide and multimarker approaches in cardiovascular medicine. (2003) (3)
- FP071SAFETY AND EFFICACY OF SODIUM ZIRCONIUM CYCLOSILICATE FOR LONG-TERM TREATMENT OF HYPERKALAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE: RESULTS FROM AN OPEN-LABEL, PHASE 3 STUDY (2018) (3)
- Uncovering heart failure in patients with bronchospasm: Rationale for the early use of B-type natriuretic peptide in the emergency department (2003) (3)
- Differences in Vaccine and SARS-CoV-2 Replication Derived mRNA: Implications for Cell Biology and Future Disease (2021) (3)
- Treatment of Orthostatic Hypotension Due to Autonomic Dysfunction (Neurogenic Orthostatic Hypotension) in a Patient with Cardiovascular Disease and Parkinson's Disease (2019) (3)
- Abstract 16610: Efficacy and Safety of Sodium Zirconium Cyclosilicate to Treat Hyperkalemia Among Patients Taking Renin-Angiotensin-Aldosterone System Inhibitors in a 12-Month, Open-Label, Phase 3 Study: A Post Hoc Subgroup Analysis (2017) (3)
- 1001-25 Primary results of the rapid emergency department heart failure outpatient trial (REDHOT): A multicenter trial examining B-type natriuretic peptide levels, emergency physician decision making and outcomes in patients presenting with shortness of breath (2004) (3)
- Implantable Loop Recorder Monitoring and the Incidence of Previously Unrecognized Atrial Fibrillation in Patients on Hemodialysis (2021) (3)
- The independent contribution to elevations in B-type natriuretic peptide from atrial fibrillation (2002) (3)
- Commentary: contrast-induced nephropathy and long-term adverse events: cause and effect? (2009) (3)
- SP421SODIUM ZIRCONIUM CYCLOSILICATE FOR HYPERKALAEMIA IN PATIENTS WITH DIABETES MELLITUS: RETROSPECTIVE ANALYSIS OF A 12 MONTH OPEN LABEL, PHASE 3 STUDY (2018) (3)
- B-type natriuretic peptide adds to clinical judgement in the diagnosis of heart failure: a bayesian analysis from the BNP multinational study (2002) (3)
- Phosphate Control: The Next Frontier in Dialysis Cardiovascular Mortality (2021) (3)
- Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure: invasive hemodynamic parameters and clinical outcomes. (2021) (3)
- Ticlopidine and TTP after coronary stenting. (1999) (3)
- Caloric expenditure in the morbidly obese using dual energy X-ray absorptiometry. (2006) (3)
- An Integrated Approach for Cardiorenal Management (2014) (3)
- Impaired Culprit Vessel Flow in Acute Coronary Syndromes Ineligible for Thrombolysis (2000) (3)
- Frequency of atrial arrhythmias after atrial flutter ablation and the effect of presenting rhythm on the day of ablation (2018) (3)
- Do implantable cardioverter-defibrillators improve survival in dialysis patients after cardiac arrest? (2006) (3)
- Cardiometabolic-Renal Disease in South Asians: Consensus Recommendations from the Cardio Renal Society of America (2019) (3)
- Major Adverse Renal and Cardiovascular Events following Intra-Arterial Contrast Media Administration in Hospitalized Patients with Comorbid Conditions (2021) (2)
- Predicting Acute Kidney Injury in the Catheterization Laboratory. (2016) (2)
- Roles for SGLT2 Inhibitors in Cardiorenal Disease. (2022) (2)
- Nomenclature for Kidney Function from KDIGO: Shortcomings of Terminology Oversimplification (2021) (2)
- Interpretation of Positive Troponin Results Among Patients with and Without Myocardial Infarction (2017) (2)
- Comparison of Survival in Patients with Clinically Significant Tricuspid Regurgitation with and without Heart Failure (From the Optum Integrated File). (2020) (2)
- Abstract 1889: Cardiac Resynchronization Therapy With Biventricular Pacing Improves Renal Function in Heart Failure Patients With Reduced Glomerular Filtration Rate (2007) (2)
- The Economic Impact of Mitral Regurgitation on Patients With Medically Managed Heart Failure. (2019) (2)
- Abstract 13555: Acute Efficacy of Sodium Zirconium Cyclosilicate (ZS-9) in Patients on Mineralocorticoid-Receptor Antagonists: Analysis From Two Phase 3 Studies (2015) (2)
- Epidemiology of systolic and diastolic dysfunction heart failure in 3,471 urban patients (2002) (2)
- A Call to Action to Develop Integrated Curricula in Cardiorenal Medicine. (2017) (2)
- BH-04: Psychosocial trends related to weight regain after bariatric surgery (2008) (2)
- Winter storm warning: Snow removal may be hazardous to your (patient’s) health (2004) (2)
- Role of Ischemic Heart Disease in Major Adverse Renal and Cardiac Events Among Individuals with Heart Failure with Preserved Ejection Fraction (From the TOPCAT Trial). (2020) (2)
- SARS-CoV-2 mass vaccination: Urgent questions on vaccine safety that demand answers from international health agencies, regulatory authorities, governments and vaccine developers (2021) (2)
- Which patients with left ventricular dysfunction require chronic anticoagulation? A prospective analysis (1998) (2)
- The effect of diabetes on B-type natriuretic peptide levels in patients with acute dyspnea (2002) (2)
- The healthcare burden of disease progression in medicare patients with functional mitral regurgitation (2019) (2)
- Discordance between estimated and measured changes in plasma volume among patients with acute heart failure (2021) (2)
- Early multidrug treatment of SARS-CoV-2 (COVID-19) and decreased case fatality rates in Honduras (2021) (2)
- Comparison of reflex, resistance training, and core activities using change in blood pressure over time after spontaneous coronary artery dissection (2019) (2)
- Impact of renin-angiotensin-aldosterone system inhibitor continuation on outcomes for patients with severe coronavirus disease 2019 manifestations. (2021) (2)
- B-type natriuretic peptide and echocardiography in the surveillance of severe mitral regurgitation prior to valve surgery. (2009) (2)
- The benefit of an early invasive strategy in women versus men with non-ST-elevation acute coronary syndromes: A collaborative meta-analysis of randomized trials (2007) (2)
- Usefulness of Combined Renin-Angiotensin System Inhibitors and Diuretic Treatment In Patients Hospitalized with COVID-19 (2022) (2)
- Statistical Analysis Methods Applied to Early Outpatient COVID-19 Treatment Case Series Data (2022) (2)
- Key updates in Cardio-Nephrology from 2018: springboard to a bright Future. (2018) (2)
- Goal-Directed Heart Failure Care in Patients With Chronic Kidney Disease and End-Stage Renal Disease. (2016) (2)
- Mitogen Activated Protein Kinase (MAPK) Activation, p53, and Autophagy Inhibition Characterize the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein Induced Neurotoxicity (2022) (2)
- Clinical Utility of a Biomarker to Detect Contrast-Induced Acute Kidney Injury during Percutaneous Cardiovascular Procedures (2022) (2)
- Usefulness of Percutaneous Closure of Patent Foramen Ovale for Hypoxia (2015) (2)
- Long-term follow-up of lesion-specific outcomes comparing drug-eluting stents and bare metal stents in diseased saphenous vein grafts. (2013) (2)
- Calling for targeted trials in cardiorenal syndromes. (2014) (2)
- Advanced lipid testing: when, why, and in whom? (2014) (2)
- Nutraceutical meal replacements: more effective than all-food diets in the treatment of obesity (2007) (2)
- Overview of B-type natriuretic peptide as a blood test. Roundtable discussion. (2006) (2)
- Lessons learned from acute myocardial infarction in patients with chronic kidney disease (2009) (2)
- Potential, but unobserved, adverse cardiovascular effects from endurance exercise reply (2012) (2)
- Drug-eluting coronary stents in patients with kidney disease. (2011) (2)
- Prevention Guidelines as Failed Minimal Standards of Care. (2020) (2)
- Chronic kidney disease as a cardiovascular risk state and considerations for the use of statins. (2008) (2)
- Coronary Angiography Before and After Renal Transplantation (2011) (2)
- Determinants of the Resolution of Type 2 Diabetes After Bariatric Surgery (2008) (2)
- Natriuretic Peptides in Patients with Renal Failure (2008) (2)
- Epidemiology and predictors of contrast-induced nephropathy (2005) (2)
- Rate of major adverse renal or cardiac events with iohexol compared to other low osmolar contrast media during interventional cardiovascular procedures (2018) (2)
- P33: Relation between degree of weight loss after bariatric surgery and reduction in high-sensitivity C-reactive protein (2008) (2)
- Primary results of the BNP multinational study: B-type natriuretic peptide in the emergency diagnosis of heart failure (2002) (2)
- Heart-Kidney Cross-Talk (2019) (2)
- The Reply (2021) (1)
- Ranolazine: focusing on angina pectoris. (2006) (1)
- Regarding: “Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019” (2021) (1)
- 859-2 Utility of B-natriuretic peptide levels in predicting outcome of hospitalized patients with congestive heart failure: Results of the breathing not properly (BNP) multinational study (2004) (1)
- Hazards of Contrast-Induced Acute Kidney Injury in Elderly Women (2009) (1)
- Use of VE/VCO2 slope Corrected for Peak VO2 as a Predictor of Post-Surgical Complications in Morbidly Obese Patients: 686 (2007) (1)
- Patient Care after Percutaneous Coronary Artery Interventions (1998) (1)
- Serum Cystatin C in the Estimation of Glomerular Filtration on Chronic Angiotensin‐Converting Enzyme Inhibitor Therapy: An Illustrative Case Report (2009) (1)
- Healthcare utilization in clinically significant tricuspid regurgitation patients with and without heart failure. (2020) (1)
- Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure. (2004) (1)
- Limitations of transoesophageal echocardiogram in acute ischaemic stroke (2020) (1)
- Arrhythmia: Predicting survival in out-of-hospital cardiac arrest (2000) (1)
- Usefulness of Statins as Secondary Prevention Against Recurrent and Terminal Major Adverse Cardiovascular Events. (2022) (1)
- Abstract 212: Integration of Multiple Cardiac Biomarkers into a Disease-Specific Score: Relationship to Clinical Status and Therapeutic Intensity (2016) (1)
- Urinary Metabolites in Patients Undergoing Coronary Catheterization Via the Radial Versus Femoral Artery Approach (2017) (1)
- Event dependence in the analysis of cardiovascular readmissions postpercutaneous coronary intervention (2019) (1)
- Clinical Context of Dyskalemias Across the Heart Failure Spectrum and Their Associated Adverse Outcomes. (2019) (1)
- The future of CKD detection: the role for the Kidney Early Evaluation Program. (2014) (1)
- Clinical effectiveness evaluation of an emergency department cardiac decision unit (2001) (1)
- Early Multidrug Outpatient Treatment of SARS-CoV-2 Infection (COVID-19) and Reduced Mortality Among Nursing Home Residents (2021) (1)
- Textbook of Cardiorenal Medicine (2021) (1)
- Cardiac Electromechanical Abnormalities in Hemodialysis Patients: Indicators of Cardiomyopathy and Future Risk? (2015) (1)
- Circulating plasma dipeptidyl dipeptidase 3 and the prognosis of cardiogenic shock (2019) (1)
- Heart Attack and Kidney Attack: Evolution of Lay and Clinical Terms for Spontaneous, Acute Organ Injury Syndromes (2014) (1)
- Co-Management of COVID-19 and Heart Failure During the COVID-19 Pandemic: Lessons Learned (2022) (1)
- POOR AEROBIC FITNESS PREDICTS COMPLICATIONS ASSOCIATED WITH BARIATRIC SURGERY (2005) (1)
- Abstract 212: Integration of Multiple Cardiac Biomarkers into a Disease-Specific Score: Relationship to Clinical Status and Therapeutic Intensity (2016) (1)
- Ventricular Septal Myectomy for the Treatment of Left Ventricular Outflow Tract Obstruction Due to Fabry Disease. (2020) (1)
- A randomized trial of prevention measures in patients at high risk for contrast nephropathy: initial results of the PRINCE study (1998) (1)
- Performance of cardiac troponin I in the exclusion of myocardial infarction in patients with advanced renal disease (2002) (1)
- Integration of the clinical laboratory in cardiovascular medicine. (2010) (1)
- KEEP 2009: Tenth anniversary of the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) (2010) (1)
- Management of Cardiovascular Disease in Chronic Kidney Disease (2014) (1)
- Theophylline or aminophylline for the prevention of contrast-induced acute kidney injury. (2012) (1)
- Equipoise on opening chronic total occlusions. (2002) (1)
- AHA Scientific Statement Bariatric Surgery and Cardiovascular Risk Factors A Scientific Statement From the American Heart Association (2011) (1)
- Healthcare utilization and guideline-directed medical therapy in heart failure patients with reduced ejection fraction. (2021) (1)
- B-type natriuretic peptide and renal function in the diagnosis of heart failure: An analysis from the BNP multinational study (2003) (1)
- Optimal dietary intake for cardiovascular risk reduction (2009) (1)
- 354 Disease State Awareness, Kidney Disease, and Relationship to ESRD and Death (2011) (1)
- Future Therapeutic Prospects for Treatment of Cardiorenal Syndromes (2015) (1)
- Epidemiology and Prevention Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Statement From the American Heart Association Councils on Kidney in Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A (2011) (1)
- 162: Chronic Kidney Disease and Cardiovascular Disease in Volunteer and Randomly Selected Populations: KEEP and NHANES (2008) (1)
- P58: The effect of gastric bypass on vitamin D (2008) (1)
- Correction: Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis Study. (2023) (1)
- Transplantation: Coronary angiography prior to renal transplantation (2010) (1)
- Update from the International Society on Hypertension in Blacks. (2002) (1)
- CLINICAL CHARACTERISTICS AND EPIDEMIOLOGY OF STABLE CORONARY SYNDROME WITHIN THE SPECTRUM OF CHRONIC CORONARY SYNDROME (2006) (1)
- Statin therapy in renal disease: Harmful or protective? (2007) (1)
- Computation of a cardiac severity score with left-censored biomarkers for patients with heart failure (2017) (1)
- Usefulness of coronary angiography in patients with left atrial myxoma (2020) (1)
- The Potential Role of Hydroxy Methylbutyrate (HMB) in theManagement of Lean Body Mass Loss in Older Adults with Heart Failureand Cardiac Cachexia (2015) (1)
- BH-08: Alcohol consumption patterns after bariatric surgery (2008) (1)
- Cardiovascular Issues and Renal Disease (2014) (1)
- Emerging practice patterns and outcomes of percutaneous aortic balloon valvuloplasty in patients with severe aortic stenosis. (2011) (1)
- Acute kidney injury in cardiogenic shock: in search of early detection and clinical certainty (2018) (1)
- Oxygen Consumption Changes During EECP Treatment in Patients with and without Coronary Artery Disease (2004) (1)
- Angiotensin converting enzyme inhibitors and beta-blockers in African Americans with heart failure. (2003) (1)
- Malnutrition, obesity, and undernutrition in chronic kidney disease (2018) (1)
- Predictability of left ventricular thrombus by mitral regurgitation. (1999) (1)
- Peter Andrew McCullough, MD, MPH: an interview with the editor. (2014) (1)
- Abstract 20073: Prevention of Contrast-Induced Acute Kidney Injury: A Mixed Methods Analysis Running Title: Acute Kidney Injury Prevention (2010) (0)
- Front & Back Matter (2018) (0)
- 38 Race Does Not Influence ESRD and Mortality in Obese Patients with CKD Stages 3-4: Results From The Kidney Early Evaluation Program (KEEP) (2011) (0)
- LDL-C Therapeutic Target Attainment in Patients with Homozygous Familial Hypercholesterolemia treated with Lomitapide (2018) (0)
- Contents Vol. 127, 2014 (2014) (0)
- Abstract 17257: The Association Between Diet Quality After Diabetes Diagnosis and Major Cardiovascular Events in Women With Type 2 Diabetes Mellitus (2014) (0)
- 1934 Atrioesophegeal Fistula, a Rare but Devastating Cause of Upper Gastrointentinal Bleeding (2019) (0)
- Ambulatory Worsening of Renal Function in Heart Failure With Preserved Ejection Fraction. (2021) (0)
- Adverse Events Following Coronary Angiography And Cardiac Surgery (2018) (0)
- Conventional risk factors and cardiac events--debunking an old myth about prevalence. (2004) (0)
- Cardiovascular outcomes and renal disease. Authors' reply (2002) (0)
- 1296: A Lethal Case of Influenza and Type 5 Cardiorenal Syndrome (2013) (0)
- Fitness and strength in young adulthood and protection from future heart failure (2017) (0)
- Analysing risk in heart failure: a Kalium check (2020) (0)
- JACC March 19,2003 ABSTRACTS-Myocardial Ischemia and Infarction 337A (2016) (0)
- Shifting statins from clinic to critical care. (2002) (0)
- Novel Developments in Acute Kidney Injury (2016) (0)
- Asthma, chronic beta-agonist use, and the development of dilated cardiomyopathy: Primary results from the ABCHF study (1999) (0)
- Screening for SARS-CoV-2 via PCR and serological testing in asymptomatic healthcare workers (2021) (0)
- Common laboratory parameters as indicators of multi‐organ dysfunction in acute heart failure (2019) (0)
- Failure of β-blockers in the reduction of perioperative events: Where did we go wrong?: Response to the letter to the Editor by Souza et al (2007) (0)
- Definitions, Epidemiology, and Implications (2014) (0)
- Improving detection of cardiac surgery-associated acute kidney injury. (2014) (0)
- Abstract 131: Recurrent Acute Cardiovascular Events and Statin Use (2018) (0)
- 1049-108 B-type natriuretic peptide and chest radiograph findings as indicators of systolic dysfunction in patients presenting with acute dyspnea (2004) (0)
- Transcatheter Aortic Valve Replacement (TAVR)-associated Acute Kidney Injury: An Update. (2023) (0)
- The Reply (2021) (0)
- Journal Watch: Our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of Clinical Practice (2013) (0)
- Contents Vol. 127, 2014 (2014) (0)
- Cardiorenal Syndrome: A Call to Action for a Pressing Medical Issue. (2018) (0)
- Toxic Nephropathy Due to Radiocontrast Media (2010) (0)
- Contents Vol. 44, 2017 (2017) (0)
- Gastric Outlet Obstruction Caused by Crohn’s Disease: 1514 (2014) (0)
- Predicting outcomes after cardiopulmonary resuscitation. Authors' reply (2001) (0)
- The Reply (2021) (0)
- 2 Bleeding Risk : The Dark Side of Anticoagulant Drugs (0)
- Assessing appropriateness of coronary intervention. (2011) (0)
- Early ambulatory multidrug therapy for SARS-CoV-2 (COVID-19) infection. (2020) (0)
- Age, Sex, Symptoms, and the Prevalence of Significant Coronary Artery Disease by Coronary Computed Tomographic Angiography (2012) (0)
- Abstract 3048: A Prospective Randomized Trial of Blood B-type Natriuretic Peptide Levels Informing Management after Elective Coronary Artery Bypass Grafting (2007) (0)
- Impact of a Short-Term Multidisciplinary Treatment Program for Obese Children: 2463 (2008) (0)
- THE IMPACT OF MITRAL REGURGITATION ON MORTALITY AND HEART FAILURE ADMISSIONS IN NEWLY DIAGNOSED HEART FAILURE PATIENTS (2019) (0)
- CorrespondenceResponse to letter to the editor (2011) (0)
- Evaluation of Cardiorespiratory Fitness in Morbidly Obese Adults: A Feasibility Study (2004) (0)
- Front & Back Matter (2014) (0)
- 163: Racial and Gender Differences in Prevalence and Predictors of Anemia of Chronic Kidney Disease: KEEP and NHANES 1999-2004 (2008) (0)
- FP804TWO-YEAR DURABILITY OF IMPROVEMENTS IN EGFR WITH BARDOXOLONE METHYL IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: THE LARIAT STUDY (2018) (0)
- Abstract 151: Therapeutic Intensity in Medically Managed Incident Heart Failure Patients with and without Mitral Regurgitation: A Claims Based Analysis (2019) (0)
- Contents Vol. 109, 2008 (2008) (0)
- P0229APPLICATION OF A RISK MITIGATION STRATEGY TO PREVENT EXCESS CARDIOVASCULAR RISK IN PULMONARY HYPERTENSION: LARIAT STUDY (2020) (0)
- Energy Expenditure, Epicardial Adipose Tissue and Cardiorespiratory Fitness in Morbidly Obese Adults: 2154 (2007) (0)
- SUPERIOR SINUS VENOSUS DEFECT AND PERSISTENT LEFT-SIDED SUPERIOR VENA CAVA WITH RIGHT HEART ENLARGEMENT IN AN ASYMPTOMATIC MIDDLE-AGED WOMAN (2019) (0)
- Predicting outcomes after cardiopulmonary resuscitation. (2001) (0)
- Response to LTE. #2005-624 - Schwam (2006) (0)
- A Multidisciplinary School Intervention To Improve Nutritional Knowledge, Increase Physical Activity, And Reduce Body Mass: 1543 (2009) (0)
- PCV53 THERAPEUTIC INTENSITY ALGORITHM IS ASSOCIATED WITH ANNUAL EXPENDITURES IN MEDICALLY MANAGED INCIDENT HEART FAILURE PATIENTS WITH AND WITHOUT MITRAL REGURGITATION (2019) (0)
- Ari Cedars Giovanni Filardo (2017) (0)
- PCV116 USING ADMINISTRATIVE CLAIMS DATA TO ESTIMATE THERAPEUTIC INTENSITY IN MEDICALLY MANAGED HEART FAILURE PATIENTS (2019) (0)
- The impact of chronic renal insufficiency on heart failure mortality after hospitalization (1999) (0)
- Six-Month Outcomes for COVID-19-Negative Patients With Acute Myocardial Infarction Before Versus During the COVID-19 Pandemic (2022) (0)
- Letter by Palazzuoli et al regarding article, "Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function". (2012) (0)
- TRENDS IN THE PREVALENCE OF ACUTE KIDNEY INJURY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (2010) (0)
- Best of the ACC 2010 Scientific Session (2010) (0)
- CONTEMPORARY PRACTICE PATTERNS RELATED TO THE RISK OF ACUTE KIDNEY INJURY IN THE CATHETERIZATION LABORATORY: RESULTS FROM AN INTERNATIONAL SURVEY OF SOCIETY OF CARDIOVASCULAR ANGIOGRAPHY AND INTERVENTION (SCAI) CARDIOLOGISTS (2016) (0)
- Degree of Beta-Blockade and Outcomes in Patients with Acute Coronary Syndrome (2014) (0)
- Front & Back Matter (2020) (0)
- A hospital employee cholesterol challenge usingspreads containing plant stanol esters to help reduce total and LDL-cholesterol (2001) (0)
- Cardiorespiratory Fitness: Relation to Body Mass Index Among the Morbidly Obese and Superobese (2006) (0)
- Six-Month Outcomes for C OVID-19 Negative Patients (2021) (0)
- Journal Watch: Our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field ofClinical Practice (2012) (0)
- B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure Analysis From Breathing Not Properly (BNP) Multinational Study Clinical Investigation and Reports (2002) (0)
- THE ECONOMIC IMPACT OF MITRAL REGURGITATION ON MEDICALLY MANAGED INCIDENT HEART FAILURE PATIENTS (2019) (0)
- Guidelines for Exercise Testing in Diabetics Starting an Exercise Program (2009) (0)
- Reply: Vitamin E May Protect Against Contrast-Induced Acute Kidney Injury. (2017) (0)
- B-type natriuretic peptide in the emergency diagnosis of diastolic dysfunction heart failure (2002) (0)
- Contents Vol. 37, 2013 (2013) (0)
- Estimated glomerular filtration rate: why is it important? (2007) (0)
- Cardiorespiratory Fitness and Physical Activity of Morbidly Obese Individuals Measured by a Body Sensor: 2259 (2008) (0)
- Cardiovascular Effects of Excess Growth Hormone: How Real is the Threat? (2023) (0)
- Save the Date — Call for Abstracts (2015) (0)
- Outcomes studies and the biomedical research enterprise. (2002) (0)
- Time-Course Increases in Cardiorespiratory Fitness after Bariatric Surgery: Considerations Regarding Follow-up Assessment (2006) (0)
- P-99: Gastric bypass surgery is associated with improvement in renal function, independent of baseline hypertension or degree of weight loss (2010) (0)
- Management of Chronic Coronary Disease and Acute Coronary Syndromes in Patients with Chronic Kidney Disease (2011) (0)
- Front & Back Matter (2019) (0)
- Peak oxygen consumption and heart rate recovery in patients with the obstructive sleep apnea syndrome. (2009) (0)
- POS-055 ESTIMATED VERSUS MEASURED GLOMERULAR FILTRATION RATE IN ACUTE DECOMPENSATED HEART FAILURE (2021) (0)
- 11: Access to Health Care in Adults Evaluated for Chronic Kidney Disease: Findings From the Kidney Early Evaluation Program (2010) (0)
- Effect of combined renin angiotensin aldosterone inhibitors and diuretic treatment among patients hospitalized with SARS-CoV-2 Infection COVID-19 (2021) (0)
- 1056-142 Investigation of myocardial-gated SPECT imaging as an initial strategy in heart failure: The IMAGING in heart failure study (2004) (0)
- FP152EFFECT OF BARDOXOLONE METHYL TREATMENT ON URINARY ALBUMIN IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE - POST-HOC ANALYSIS FROM BEAM AND BEACON (2018) (0)
- P-41: Low resting metabolic rate is associated with low cardiorespiratory fitness, low vitamin D and hyperuricemia in bariatric surgery patients (2010) (0)
- Normalization of Serum Potassium With Sodium Zirconium Cyclosilicate (ZS-9) in Patients With Heart Failure (2015) (0)
- NATRIURETIC PEPTIDE TESTING AND APACHE II SCORES FOR THE EVALUATION AND PREDICTION OF OUTCOME IN ACUTELY ILL PATIENTS: A PROSPECTIVE COHORT STUDY (2007) (0)
- Increased F2-isoprostane oxidative stress in coronary artery disease (CAD) patients with poor aspirin-induced thromboxane B2 inhibition (2016) (0)
- Chronic kidney disease: The silent killer after coronary angioplasty (2003) (0)
- CRT-200.07 Six-Month Outcomes for COVID-19-Negative Patients With Acute Myocardial Infarction Before Versus During the COVID-19 Pandemic (2022) (0)
- 170 - Safety and Efficacy of Ferric Citrate in Patients with Nondialysis-Dependent Chronic Kidney Disease and Iron Deficiency Anemia: Post Hoc Analysis in Patients with or Without Heart Failure (2017) (0)
- High Sensitivity C-reactive Protein In The Morbidly Obese: Risk Predictor Or Reflection Of Adiposity And Deconditioning? 1507 10:30 AM - 10:45 AM (2005) (0)
- High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention From the American Heart Association Councils on Kidney in Cardiovascular Disease, Kidney Disease as a Risk Factor for Development of Cardiovascular Disease : A Statement (2013) (0)
- Screening and Diagnosing Cardiovascular Disease in Chronic Kidney Disease (2014) (0)
- Abstract 1538: Acute Cardiac Effects of Marathon Running: Evidence of Right-Heart Overload (2009) (0)
- can–Americans with hypertension (AASK) and the other in patients screened for CKD (CRIC), variants in the gene for APOL1 were assessed according to whether they had two high-risk APOL1 variants (APOL1 (2014) (0)
- Editorial: Robertsonian Perspectives on Atherosclerosis: The Power of Direct Observation. (2018) (0)
- PowerPoint Slides for: Renal Function and Scaled Troponin in Patients Presenting to the Emergency Department with Symptoms of Myocardial Infarction (2017) (0)
- PEAK OXYGEN CONSUMPTION AND THE VE/VCO2 SLOPE IN MORBIDLY OBESE MEN AND WOMEN: INFLUENCE OF SUBJECT EFFORT AND BODY MASS INDEX (2007) (0)
- The Reply (2021) (0)
- Are We Routinely Underestimating Functional Capacity, Expressed as Metabolic Equivalents, in Obese Adults?: 2718 (2010) (0)
- Front & Back Matter (2020) (0)
- 720-2 Predictors of Acute Complications After Percutaneous Coronary Revascularization with New Devices (1995) (0)
- SURVIVAL IN CLINICALLY SIGNIFICANT TRICUSPID REGURGITATION PATIENTS WITH AND WITHOUT HEART FAILURE: EVIDENCE FROM OPTUM'S INTEGRATED DATABASES (2020) (0)
- Front & Back Matter (2019) (0)
- Abstract 16873: Safety and Efficacy of Alirocumab in Patients With Atherosclerotic Cardiovascular Disease, Based on Statin Intensity: Pooled Analyses of 5 Placebo-controlled Phase 3 Trials (2016) (0)
- Front & Back Matter (2020) (0)
- Front & Back Matter (2019) (0)
- Editorial Board (2010) (0)
- What Role Does Mannitol Play in Preventing Contrast Nephropathy? a Prospective Analysis (1998) (0)
- CHANGES IN RENAL PERFUSION PRESSURE DURING HEMODYNAMICALLY GUIDED THERAPY IS ASSOCIATED WITH WORSENING RENAL FUNCTION (2017) (0)
- MP418VADADUSTAT DOES NOT PROLONG CORRECTED QT INTERVAL IN A THOROUGH QTC STUDY IN HEALTHY SUBJECTS (2017) (0)
- Cardiovascular Risk Reduction in Patients With Chronic Kidney Disease Targeting In fl ammation With Canakinumab* (0)
- Editorial board (1993) (0)
- MORTALITY AND GUIDELINE DIRECTED MEDICAL THERAPY IN HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION: EVIDENCE FROM REAL WORLD DATA (2021) (0)
- Mediators of the Effects of Canagliflozin on Heart Failure: Central Role of the Cardiorenal Axis. (2020) (0)
- Aortic Stenosis and Aortic Valve Replacement Among Patients with Chronic Kidney Disease: A Narrative Review. (2023) (0)
- The Low-Density Lipoprotein Cholesterol Hypothesis: An Update (2020) (0)
- Contents Vol. 9, 2019 (2019) (0)
- Coronary Atherosclerotic Heart Disease and Chronic Kidney Disease (2013) (0)
- A Contrast in Risk:Radiographic Imaging in theRenally Compromised Patient (2019) (0)
- Rationale and methods for assessment of coronary flow prior to coronary intervention: where are we headed? (2002) (0)
- Progression of Coronary Artery Calcification: Not Down-and-Out—Reply (2010) (0)
- Implications of Chronic Kidney Disease on the Epidemiology of Cardiovascular Disease (2020) (0)
- THE IMPACT OF PREOPERATIVE LENGTH OF STAY ON MAJOR ADVERSE RENAL AND CARDIAC EVENTS (2019) (0)
- A Commentary on Treatment of Tricyclic Antidepressant Overdose (2019) (0)
- Subject Index Vol. 109, 2008 (2008) (0)
- Decoding Acute Myocardial Infarction among Patients on Dialysis. (2017) (0)
- Association of urinary 11-dehydro-thromboxane B2 and F2-isoprostanes with mortality in aspirin-treated stable coronary artery disease patients (2018) (0)
- Front & Back Matter (2020) (0)
- TCT-432 The Economic Impact of Clinically Significant Tricuspid Regurgitation (2019) (0)
- Impaired Exercise Capacity in the Morbidly Obese: Implications for Exercise Prescription: 2733 (2010) (0)
- Genetic Association of the ACE Gene Polymorphisms with Essential Hypertension in Korean Females (2006) (0)
- New onset heart failure: influence of gender on underlying pathophysiology (2004) (0)
- Our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of clinical practice (2014) (0)
- Ability to Achieve Maximal Oxygen Consumption During Exercise Testing in Morbidly Obese Patients (2004) (0)
- Novel Biomarkers of Chronic Cardiorenal Disease (2020) (0)
- Editorial Board (2011) (0)
- Front & Back Matter (2018) (0)
- Early Statin Use and Recurrent Major Adverse Cardiovascular Events: A Multicenter Study (2020) (0)
- The Promise of next generation sequencing micro RNA for the discovery of new targets in contrast induced acute kidney injury. (2019) (0)
- Coronary artery disease. Age, sex, symptoms, and the prevalence of significant coronary artery disease by coronary computed tomographic angiography. (2012) (0)
- Cardiorenal Syndromes in Critical Care: Preface (2010) (0)
- The Reply (2021) (0)
- Ximelagatran and Oral DirectThrombin Inhibition (2004) (0)
- Cardiorenal Management: An Integrated Approach (2014) (0)
- Correlation Between Troponin Values and Echocardiographic Findings in Children Following Global lschemic Cardiac Arrest (2003) (0)
- SARS-CoV-2 mass vaccination: Urgent questions on vaccine safety that demand answers from international health agencies, regulatory authorities, governments and vaccine developers (2021) (0)
- Mediators of the Effects of Canagliflozin on Heart Failure: Central Role of the Cardiorenal Axis. (2020) (0)
- TCT CONNECT-213 Clinical Characteristics and Outcomes of Patients With COVID-19 and STEMI Treated With Fibrinolytic Therapy (2020) (0)
- Prediction of Metabolic Syndrome based on Non-invasive Measurement Features for Chronic Disease Management (2022) (0)
- Preface. Ximelagatran and oral direct thrombin inhibition. (2004) (0)
- Statin Update: Intolerance, Benefit, and Beyond (2019) (0)
- Experience in the Management of Upper Gastrointestinal Bleeding and Outcomes in Patients Taking Dabigatran Compared with Warfarin: A Retrospective, Comparative Study: 1555 (2013) (0)
- Cardiac Resynchronization Therapy Improves Renal Function in Heart Failure Patients with Reduced Glomerular Filtration Rate (2007) (0)
- Hypertrophic Cardiomyopathy and Sudden Cardiac Death in an Elite Athlete: Cardiac Rehabilitation and Exercise Intervention: 1102 (2008) (0)
- P-92: Effect of circular staple height on gastrojejunostomy complications in gastric bypass (2010) (0)
- Dietary Behaviors and Knowledge Among Urban Pre-Adolescents: 1581 (2007) (0)
- 5: Albuminuria in Obese Adults is Associated With Hypertension and Sleep Disturbance (2008) (0)
- Poster 300: Pertinent Abduction Angle for Reduction of Shoulder Subluxation in the Hemiplegic Patients (2008) (0)
- Abstract 3749: Chronic Kidney Disease and Risk for Premature Cardiovascular Disease (2007) (0)
- Relationship between Respiratory Muscle Strength and Cardiac Function in Duchenne Muscular Dystrophy (2009) (0)
- The "null effect" of low-density lipoprotein cholesterol lowering on a modest baseline intima-media thickness: lessons learned from the ENHANCE trial. (2008) (0)
- Advances in the Management of Valvular Heart Disease (2013) (0)
- A novel strategy to prevent contrast nephropathy: “Continuous hemodiafiltration” (2020) (0)
- Appendix 2: 11th Acute Dialysis Quality Initiative (ADQI) Consensus Group (2013) (0)
- 207: Prevalent Components of Cardiometabolic Syndrome and Cardiovascular Disease from the Kidney Early Evaluation Program (KEEP) (2008) (0)
- Contents Vol. 39, 2014 (2014) (0)
- A comparison of bedside B-type natriuretic peptide versus echocardiographic determination of ejection fraction in the diagnosis of heart failure (2003) (0)
- Abstract 15609: The Effect of Contrast-induced Acute Kidney Injury in High Risk Patients Undergoing Cardiac Surgery (2016) (0)
- Case 1 : galectin-3 and the risk of future heart failure (2014) (0)
- Prediction of In-hospital Survival After Sudden Cardiac Death: Derivation and Validation of a Clinical Model (1998) (0)
- 53: Correlates of Chronic Kidney Disease (CKD) Among Hispanic Subgroups: Results from the Kidney Early Evaluation Program (KEEP) (2007) (0)
- Iconographies supplémentaires de l'article : Awareness of Kidney Disease and Relationship to End-stage Renal Disease and Mortality (2012) (0)
- 41 Poor Glycemic Control but not Dyslipidemia is Associated with Albuminuria in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM): A Kidney Early Evaluation Program (KEEP) Report (2011) (0)
- Front & Back Matter (2019) (0)
- Iso-Osmolar Contrast Media and Adverse Renal and Cardiac Events After Percutaneous Cardiovascular Intervention (2017) (0)
- Optimal Definition of Chronic Kidney Disease as a Cardiovascular Risk State (2008) (0)
- Relationship of platelet thromboxane inhibition by aspirin and all-cause mortality in patients with stable coronary artery disease. (2017) (0)
- 127: Association of Chronic Kidney Disease with Birth Weight and Gender in the Kidney Early Evaluation Program Participants (2007) (0)
- Discussion on Key Heart Failure Risk Factors in Patients With Type 2 Diabetes Mellitus (2020) (0)
- Usefulness of Heart Rate Variability for Qualitative Evaluation of Diabetic Autonomic Neuropathy (2006) (0)
- Acknowledgement to Reviewers (2010) (0)
- The Reply (2021) (0)
- Contents Vol. 1, 2011 (2011) (0)
- Influence Of Gender On Aerobic Capacity In Morbidly Obese Individuals Referred for Bariatric Surgery: 537 Board #128 3:30 PM ??? 5:00 PM (2005) (0)
- IMPACT OF ENHANCED EXTERNAL COUNTERPULSATION ON HEART FAILURE REHOSPITALIZATION AMONG PATIENTS WITH ISCHEMIC CARDIOMYOPATHY (2016) (0)
- MEDICAL THERAPY IN PATIENTS WITH FUNCTIONAL MITRAL REGURGITATION: ARE PATIENTS OPTIMIZED IN THE REAL WORLD? (2020) (0)
- Bivalirudin Provides Increasing Benefit With Declining Renal Function in Percutaneous Coronary Intervention: A Meta-Analysis of 5,035 Patients Enrolled in Three Randomized Trials (2003) (0)
- Inpatient hospitalisation and mortality rate trends from 2004 to 2014 in the USA: a propensity score-matched case–control study of hyperkalaemia (2022) (0)
- Heart Rate Recovery After Exercise Is Not Demonstrated as a Predictor of Mortality: Maybe After Treadmill-Exercise Pulmonary Venous Flow by Doppler Echocardiography: Usefulness of Diastolic Wave Deceleration (2016) (0)
- Contents Vol. 35, 2012 (2012) (0)
- P-26: Frequency and clinical correlates of vitamin A deficiency after gastric bypass surgery (2010) (0)
- Front & Back Matter (2018) (0)
- Reply: muscle strength, cardiorespiratory fitness and cardiovascular disease (2018) (0)
- Type 2 Cardiorenal Syndrome (2020) (0)
- Contents Vol. 127, 2014 (2014) (0)
- Abstract 234: Prevalence and Prognosis of Hyperkalemia in Dialysis and Non-Dialysis Patients with Acute Myocardial Infarction (2014) (0)
- P46: Determinants of the resolution of type 2 diabetes after bariatric surgery (2007) (0)
- Chronic Kidney Disease and the Cardiovascular Connection (2014) (0)
- 255: The Association of Serum Phosphorus and Pulse Pressure in Men and Women With Chronic Kidney Disease: Data From the Kidney Early Evaluation Program (2010) (0)
- Cardiovascular Disease and Chronic Kidney Disease (2020) (0)
- Self-Paced Brisk Walking is an Adequate Aerobic Training Stimulus for Morbidly Obese Patients: 2220 (2008) (0)
- Original Article Influence of myocardial ischemia on outcomes in patients with systolic versus non-systolic heart failure (2011) (0)
- Advantages of an early invasive approach in acute coronary syndromes. (2003) (0)
- Abstract 101: The Development and Initial Validation of PROMIS-Plus-HF Profile Measure (2019) (0)
This paper list is powered by the following services:
Other Resources About Peter A. McCullough
What Schools Are Affiliated With Peter A. McCullough?
Peter A. McCullough is affiliated with the following schools:
